• 10 tips to find bargains

    Susan Erasmus gives advice on how bargain hunters can get the most bang for their buck.

  • Inside Labour

    Labour's bitter breaches need to be seen in historical context, says Terry Bell.

  • Rich getting richer

    Economists differ on how to tackle the chasm between rich and poor, says Leopold Scholtz.

See More

Pfizer wins first US trial over Zoloft

Apr 19 2015 12:00

Pfizer has scored a key victory when it was cleared of liability in the first US trial involving claims that its antidepressant Zoloft can cause birth defects.


Europe watchdog seeks tighter rules on ibuprofen

Apr 13 2015 17:30

A European panel has backed tougher guidelines on ibuprofen after research found high doses of the popular painkiller are linked to an increase in cardiac risk.


UK biotech group raises $58m for RNA drive

Apr 09 2015 19:00

British biotech group Silence Therapeutics has raised £38.9m by selling two tranches of new shares at 240 pence each to develop its genetic medicine platform.


Industry makes $7 000 for each tobacco death

Mar 20 2015 19:43

The tobacco industry makes $7 000 for each of the more than 6 million people who die each year from smoking-related illness, according to the World Lung Foundation.


GSK launches $890m placement in Aspen Pharmacare

Mar 13 2015 08:14

GlaxoSmithKline has launched an $890m share sale in drug company Aspen Pharmacare, according to a source familiar with the matter.


Ascendis aims at exports, synergies, innovation

Mar 11 2015 14:45

The interim results of Ascendis Health show strong revenue growth due to comparable organic growth from strategic acquisitions over the past year.


Bidvest, PIC in talks to control half of Adcock

Mar 11 2015 11:48

Bidvest Group is in talks with a fellow shareholder in Adcock Ingram, the Public Investment Corporation, to jointly control nearly half of the struggling drugmaker.


Aspen earnings up as acquisitions kick in

Mar 05 2015 17:07

Aspen Pharmacare has reported a 22% increase in half-year profit as contributions from recent acquisitions offset the impact of unfavourable currency moves.


GSK, Norvatis sign deals worth $20bn

Mar 02 2015 20:00

GlaxoSmithKline and Novartis say they had completed a series of asset swaps worth more than $20bn that will reshape both drug makers.


Bidvest has no plans to buy all of Adcock

Mar 02 2015 12:29

The Bidvest Group has "no aspiration" to buy all of Adcock Ingram, says its chief executive as the share price of its target traded above its offer price.

Inside Fin24.com


Discovery lifts earnings, plans R5bn rights issue

Feb 24 2015 10:18

Leading health insurer Discovery is planning a rights issue to raise as much as R5bn to finance expansion, sending its shares down nearly 4%.


Adcock turnaround plan gaining traction

Feb 23 2015 16:48

Drugmaker Adcock Ingram has reported a rise in half-year headline earnings per share, a sign that a turnaround plan is gaining traction.

We're talking about:


Johannesburg has been selected to host the Global Entrepreneurship Congress in 2017. "[The congress] will ensure that small business development remains firmly on the national agenda and the radar screen of all stakeholders, the Small Business Development minister said.

10 most expensive cars In the world

This is car porn at its best!


Luxury living

Seven of the most expensive children's toys ever made
5 millionaires turned murderers
The youngest billionaires in the world and how they made it
Watch: Flying first class has never been this luxurious!

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...

Voting Booth

How do you see your boss? He/sheis:

Previous results · Suggest a vote